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INTRODUCTION
Critically ill patients, almost by definition, are catabolic and often hypermetabolic.
Although it is generally accepted that such patients would benefit from nutritional sup-
port, there are remarkably little data to support this premise.
Several experts believe that prospective, randomized, controlled studies to document
the efficacy ofnutrition support in improving outcome in critically ill patients are unlike-
ly to occur for a variety ofreasons. It is difficult to recruit acceptable (large) numbers of
patients that can be matched in terms of diagnosis, severity of illness and nutritional sta-
tus prior to intensive care unit (ICU)b admission. With the broad acceptance ofearly nutri-
tional support amongst physicians, ethical dilemmas are created in proceeding with trials
in which control groups receive no nutritional support. Finally, as Soeters et al. [1] point
out, it is likely that those patients who are most severely ill will receive the least benefit
in terms ofoutcome because of overwhelming illness. Nevertheless, nutritional depletion
is generally associated with increased morbidity and mortality, and intuitively the correc-
tion of these deficiencies should minimize the component of the adverse outcome attrib-
utable to malnutrition.
THE METABOLIC RESPONSE TO INJURY
The situation frequently confronted in the critically ill is not simply that nutrient sup-
ply is less than nutrient demand as in starvation. Critically ill patients have a state of
hypermetabolism [1, 2] initiated by a variety of causes such as shock, sepsis, thermal
injury, trauma, etc. This hypermetabolism is secondary to a number of events initiated in
large part by the same mediators seen in the systemic inflammatory response syndrome
(SIRS). There are marked increases in sympathetic activity; elevations ofglucocorticoids,
glucagon, and insulin; as well as cytokine release (tumor necrosis factor, interleukin-1,
interleukin-2); lipid-related mediators such as platelet activating factor; and a variety of
leukotrienes and prostaglandins [3-5]. Additionally, though poorly studied, it seems cer-
tain that a number ofdescribed growth factors will be shown to play an active role in the
metabolic response to injury.
The net result is dramatic as the body mobilizes substrates to meet energy require-
ments and for the hepatic production of acute phase reactants. The latter are important in
healing wounds and modulating the inflammatory response. The expense is in lean body
mass-patients often losing 10 to 20 gm ofnitrogen per day (Table 1).
a To whom all correspondence should be addressed: Jeffrey J. Lunn, M.D., F.C.C.P., Mayo Clinic,
200 First Street, SW, Rochester, MN 55905. Tel.: (507) 255-3280; Fax: (507) 255-4267; E-mail:
lunn.jeffrey@mayo.edu.
bAbbreviations: ICU, intensive care unit; SIRS, systemic inflammatory response system; TPN, total
parenteral nutrition; BCAA, branched-chain amino acid.
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Table 1. Metabolic response to injury and inflammation.
* Increased resting energy expenditure
* Increased respiratory quotient
* Markedly increased proteolysis, ureagenesis, urinary nitrogen loss
* Increased gluconeogenesis
NUTRITIONAL ASSESSMENT IN THE INTENSIVE CARE UNIT
Most measurement tools fornutritional assessment forcritically ill patients are at best
only estimates of the need for nutritional support. Virtually all of the current assessment
methods are impacted by serious illness. There is no consensus on appropriate assessment,
and there are little comparative data between assessment methodologies. If we cannot
agree on nutritional assessment, how can we agree on whether to feed, when to feed and
how to feed?
Subjective global assessment
Probably the best of the current assessment tools is the subjective global assessment
[6, 7], which involves an assessment of nutritional restriction, metabolic and nutritional
influence ofthe patient's disease, and effects upon organ function or composition. It uses
a variety of means including history, symptomatology and physical assessment. As the
title suggests, some elements are influenced by subjective weighting, yet there is a good
reproducibility, and it is abetterprediction ofpostoperative complications than most other
objective tests. It has not been well tested in critically ill patients.
Musclefunction
Changes in skeletal muscle function in response to hypocaloric diets and fasting
occur rapidly, prior to detectable changes in nitrogen or protein homeostasis. Tests of
adductor pollicis function, in response to electric stimulation, appear to be both sensitive
and specific compared to more common assessments [8]. Reciprocal changes in function
can be detected during refeeding. There is a wide variation amongst patients, however,
potentially making standardization difficult.
Blood tests
The measurements of serum albumin, transferrin or retinol-binding-prealbumin
serum complex are commonly utilized in nutritional assessments [6, 9-11]. All have
potential error introduced in critical illness as they can be influenced by events such as
infection, liver dysfunction, renal dysfunction and other processes not related to nutri-
tional status. Having said that, a decreased serum albumin is clearly associated with
increased morbidity and mortality.
Other assessment tests, such as measurement of serum fibronectin [12, 13] and
insulin-like growth factor [12, 14], have been suggestedparticularly forpatients withrenal
failure, but these studies are rarely available and their reliability not yet proven.
Anthropometry
The use ofthese standard measurements in the critically ill patient is limited because
ofvariability between observers and difficulty with reproducibility, compounded in criti-
cally ill patients because ofchanges in volume state, i.e., subcutaneous edema.
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Body weight
Body weight is a poor assessment tool in the ICU for nutrition because total body
water changes such as edema, ascites, effusions and dehydration are frequent occurrences
in the ICU. Derived indices such as body mass index are subject to similar errors.
Delayed cutaneous hypersensitivity
Delayed cutaneous hypersensitivity is a poor choice ofnutritional assessment in crit-
ically ill patients as it is altered in many conditions and by many medications commonly
seen in the ICU in the absence of malnutrition [15].
Body composition analysis
Technology now exists to measure a variety oftissue components, but they are expen-
sive and not readily available. Examples are dual energy x-ray absorptiometry, in vivo
neutron activation analysis and bioelectrical impedance. Data have not allowed an accu-
rate prediction of outcome as yet, but these technologies have the potential to overcome
many ofthe obstacles inherent in other methods ofnutritional assessment.
PHYSIOLOGICAL CONSIDERATIONS IN NUTRITION
Shock, severe illness, starvation, trauma and possibly total parenteral nutrition (TPN)
[16, 17] are associated with changes in the small intestine resulting in villous and mucos-
al atrophy and concomitant changes in permeability. These findings have led to the theo-
ry that translocation ofbacteria andendotoxin occurs as aresultofthese intestinal changes
which, in turn, leads to inflammatory and/or infectious events [18, 19]. Enteral nutrition
has been shown to improve mucosal mass, integrity, absorptive capacity and barrier func-
tion [20]. Animal studies suggest that these improvements in the gut provide an advanta-
geous outcome in terms ofsepsis [21, 22]. Human data are notquite as conclusive, but the
available evidence suggests that early enteral nutrition is superior to TPN [23, 24].
There are other physiologic implications associated with the delivery route for nutri-
tion. TPN can induce cholestasis and fatty infiltration ofthe liver. Enteral feeding releas-
es cholecystokinin, which stimulates bile flow and decreases the incidence ofcholehepat-
ic complications. Early enteral feeding has also been shown to attenuate the hormonal
response to inflammation [25]. Despite early aggressive nutrition, acute phase reactants
(proteins) are synthesized at the expense of visceral protein, and current therapy cannot
reverse the decrease in lean mass (protein wasting) that occurs in catabolic critically ill
patients.
Early enteral feeding may also have a protective effect on the gut by restoring gas-
trointestinal blood flow often compromised in critical illness. Trace elements are regulat-
ed via the gastrointestinal tract, but it is not known ifregulation continues when trace ele-
ments are given parenterally. TPN requires central venous access, which has its own
mechanical and infectious hazards. Intravenous lipid emulsions have been associated with
immunosuppression. TPN is also associated with frequent severe metabolic changes such
as hyperglycemia, acid-base disturbances and electrolyte abnormalities.
Generally, the majority of clinical evidence supports improved outcomes in patients
fed enterally as opposed to parenterally [23, 24]. Though the benefit to enteral nutrition is
thought by many to relate to its physiologic effect on the gastrointestinal tract, it makes
little difference whether it is the avoidance ofproblems associated with TPN, as opposed
to any physiologic benefit of enteral nutrition. The adage "if the gut works, use it" still
holds.
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ECONOMIC CONSIDERATIONS
In this time offiscal scrutiny, the mention ofeconomics to physicians results in imme-
diate dysphoria. In terms of nutritional support, however, it appears the right thing eco-
nomically is the right thing for most patients. The cost implications of using TPN when
the gastrointestinal tract is functional are enormous and probably unconscionable, given
the compelling data that enteral nutrition is more cost effective for a variety of reasons
[26].
TIMING: WHEN DO WE FEED?
Critically ill patients are often not previously-well patients who have reverted to star-
vation metabolism. The patients we are primarily concerned with are those that are hyper-
metabolic/hypercatabolic, with large (10 to 20 gm nitrogen per day) losses of protein in
the urine.
There remain surprisingly little firm data available to help one select the time when
nutrition should begin. Consensus at a recent conference sponsored by the National
Institutes of Health (NIH), the American Society for Clinical Nutrition (ASCN) and the
American Society for Parenteral and Enteral Nutrition (ASPEN) concluded that critical
depletion oflean tissues would occur by 14 days and that nutrition should be instituted in
those who cannot feed by seven to 10 days [27].
Limited, and controversial, evidence exists that early feeding may be beneficial and
ameliorate the inflammatory response. Early feeding is most beneficial when given enter-
ally, decreasing infections, morbidity, and mortality [23, 24]. In general, patients with crit-
ical illness (hypermetabolic and hypercatabolic) should be fed if they will not be able to
nourish themselves within five to seven days. Some centers opt for more aggressive feed-
ing, proceeding as early as is practical with supplemental nutrition. With the lack offirm
evidence, it is difficult to argue with that approach.
PRACTICAL POINTS AND COMPLICATIONS
"If the gut works, use it"-and use it maybe even if it seems not to work! Most crit-
ically ill patients will have relatively normal small bowel motility. Even those patients
with gastric and/or colonic dysmotility can tolerate small bowel feedings in the vast
majority ofinstances whether bowel sounds are present or not. Indeed, even patients with
bowel anastamosis can frequently be fed early via the enteral route [28]. A recent study
showed that upwards of90 percent ofall patients in need ofnutrition therapy could be fed
via the gastrointestinal tract when prokinetic agents such as erythromycin or cisapride
were used when indicated [29]. In those patients with some element ofmalabsorption, ele-
mental as opposed to polymeric diets may benefit. In general, one should fail enteral nutri-
tion before beginning on TPN.
ENTERAL COMPLICATIONS
Gastrointestinal problems, chiefly diarrhea, are frequent in the enterally-fed ICU
patient. It is more common in patients with low serum albumin and those on prolonged
antibiotic therapy. Diarrhea is more common when patients are fed in bolus fashion rather
than by continuous delivery. Diarrhea is often caused by a variety ofetiologies other than
tube feedings, e.g., C. difficile or sorbitol-containing medications. Diarrhea may also
result from malabsorption, lactose intolerance, intestinal atrophy or bacterial contamina-
tion of the enteral feeding itself.
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Depending upon the type ofaccess, multiple potential problems exist including endo-
tracheal placement (with potential for disaster) or dislodgment ofjejunal tubes into the
peritoneum. Other problems include nasopharyngeal irritation or infection, dysphagia and
esophageal reflux.
Potential metabolic problems are not different with enteral versus parenteral feeding
and include overfeeding; hypo- and hyperglycemia; uremia; vitamin, trace mineral and
essential fatty acid deficiencies; abnormalities of fluid and electrolyte status; and eleva-
tion of liver function tests. Enteral feeding compared to parenteral feeding, however, is
probably associated with a decreased incidence ofmetabolic problems and oflesser sever-
ity when they do occur.
The most common concern with the enteral approach revolves around aspiration. The
incidence of aspiration varies widely, depending upon the definition and type of patient
population. With proper selection, monitoring, and management, serious morbidity or
mortality from aspiration is remarkably rare [30].
COMPLICATIONS OF PARENTERAL THERAPY
The most feared complications of parenteral therapy stem from the need for central
venous access. Rates ofcomplications ofcatheter insertion are somewhat operator-depen-
dent and range up to about six percent [31], including all types of injuries from pneu-
mothorax to thoracic duct injury. In addition, there is a complication rate for maintaining
catheters in place including infections, venous thrombosis, arrhythmias, cardiac perfora-
tion with tamponade, catheter occlusion and air embolism. Other than sepsis and venous
thrombosis, the others are fortunately uncommon.
Gastrointestinal complications include cholestasis, steatosis and acalculous cholecys-
titis. The enteral advantages of maintaining gut integrity is also lost. Potential metabolic
complications ofparenteral feeding are similar, but probably on whole more frequent and
severe compared to enteral nutrition.
DIETARY ADJUVANTS AND ADDITIVES
Arginine
Arginine, an amino acid, stimulates the release of a variety of hormones including
prolactin, insulin and growth hormone. It is also a precursor for nitric oxide. It reputedly
enhances both wound healing and immune function. There are no studies, however, that
examine outcome with arginine supplementation in critical illness.
Antioxidants
As injury from oxidation is a prominent process in inflammatory states that often
accompany critical illness, it is natural to assume that inhibiting oxygen radicals would be
beneficial. There is evidence that antioxidants, such as vitamin E, may lower risk in more
chronic inflammatory conditions (i.e., coronary artery disease), but there is as yet no evi-
dence to support antioxidant therapy in critically ill patients.
Omega-3 FattyAcids
Many of the harmful mediators of SIRS are metabolites of omega-6 fatty acids, and
it has been theorized that the substitution of omega-3 fatty acids would be beneficial in
inflammatory states. Indeed, there are both animal and human data to support this [32-34].
In critical illness, the data are difficult to interpret because of study design but suggest
some benefit.
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Glutamine
Glutamine, an amino acid, serves a number ofphysiologic functions, most notably as
a precursor for glutathione (antioxidant) and as fuel for the gastrointestinal tract endothe-
lium and some blood elements. Although there are several studies that suggest benefit, the
salutary effect of glutamine remains controversial and poorly examined in terms of ran-
domized, prospective studies.
Branched-chain amino acids
Branched-chain amino acids (BCAA), particularly leucine, can stimulate protein syn-
thesis and impede degradation in vitro. This finding has led to advocating BCAA as a
mechanism to spare protein loss in critical illness. There is little or no evidence to demon-
strate clinical benefit from this approach. BCAA have been used in the treatment of
patients with hepatic encephalopathy with good results (in terms ofencephalopathy).
Growthfactors
In recent years, a multitude of growth factors (neurotensin, epidermal growth factor,
insulin-like growth factor and others) have been discovered. Large, prospective, random-
ized studies will be required to determine if any positive role exists for these substances
in nutrition support for the critically ill.
SPECIFIC CRITICAL ILLNESS
A recent intersociety conference reviewed the available published data in reference to
critical illness (trauma, sepsis, SIRS, multiple organ dysfunction syndrome, bums, acute
lung injury, acute renal failure) [24]. Despite the large volume of material reviewed, the
nature ofthe majority ofnutritional data led to remarkably scant conclusions:
* Critically ill patients have increased nutrient requirement and are hyperme-
tabolic.
* Improved clinical outcomes as aresult ofnutritional support have been inad-
equately studied.
* Begin nutrition in patients not expected to resume oral feeding for seven to
10 days.
* Trauma patients enterally fed have fewer complications than those parenter-
ally fed.
* No conclusions can be reached regarding the efficiency of specialized sub-
stances and formulas.
CONCLUSIONS
Because ofthe basic nature nutrition plays in supportive care, it is unlikely that appro-
priate adequate studies will answer these questions soon. In the meantime, the choice of
enteral nutrition in critical illness, when feasible, has advantages in terms oftheory, eco-
nomics, preponderance ofclinical opinion, and possibly outcome that make enteral nutri-
tion the route ofchoice when alimenting critically ill patients.
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